The engagement of activating receptors such as NKG2D, DNAM-1, and the natural cytotoxicity receptors NKp30, NKp44, and NKp46 is still required for the robust activation of NK cells and NK cell-mediated killing of transformed cancer cells [8, 9]. Here, KLRK1 is linked to cancer.